Results 201 to 210 of about 46,462 (246)
Some of the next articles are maybe not open access.

Obesity and Cardioprotection

Current Medicinal Chemistry, 2020
The incidence of obesity and diabetes is increasing rapidly worldwide. Obesity and metabolic syndrome are strictly linked and represent the basis of different cardiovascular risk factors, including hypertension and inflammatory processes predisposing to ischemic heart disease, which represent the most common causes of heart failure.
Femminò, Saveria   +2 more
openaire   +2 more sources

Cardioprotection

Der Anaesthesist, 2012
The demographic change is associated with an increasing number of elderly patients with serious comorbidities. The prevalence of coronary heart disease in particular increases with age and raises the risk of perioperative myocardial ischemia. In the last few years various interventions have been evaluated to lower the perioperative risk for serious ...
David J. Lefer, Roberto Bolli
openaire   +3 more sources

Opioids and cardioprotection

Pharmacology & Therapeutics, 2001
Opioid peptides and exogenous opioids such as morphine are known to exert important cardiovascular effects. However, until recently, it was not appreciated that activation of specific receptors results in a potent cardioprotective effect to reduce infarct size in experimental animals and to reduce cell death in isolated cardiomyocytes.
J E, Schultz, G J, Gross
openaire   +2 more sources

Cardioprotection With Grapes

Journal of Cardiovascular Pharmacology, 2002
Epidemiologic studies suggest that mild-to-moderate wine consumption is associated with a reduced incidence of mortality and morbidity from coronary heart disease. Because wines are produced from grapes, this study was done to determine whether the grapes were equally cardioprotective.
Jianhua, Cui   +4 more
openaire   +2 more sources

Cardioprotection: emerging pharmacotherapy

Expert Opinion on Pharmacotherapy, 2001
By the year 2020, it is predicted that acute coronary occlusion will be the major cause of death in the world. Recent advances in reperfusion therapy have substantially improved survival of patients with acute coronary syndromes. While early reperfusion reduces mortality, a time limitation exists with regard to myocardial salvage.
R J, Gumina   +3 more
openaire   +2 more sources

ARB and Cardioprotection

Cardiovascular Drugs and Therapy, 2012
A growing body of evidence has suggested that the use of angiotensin II (Ang II) type 1 (AT1) receptor blockers (ARBs) leads to a significant decrease in mortality and morbidity in patients with congestive heart failure. The AT1 receptor is a seven-transmembrane G protein-coupled receptor, and is involved in regulating the physiological and ...
Hiroshi, Akazawa   +4 more
openaire   +2 more sources

Exercise and cardioprotection

Current Opinion in Cardiology, 2002
A wealth of data indicates that performing regular exercise is an important lifestyle modification to prevent cardiovascular disease. Although not fully understood, the cardioprotection by regular exercise may be exerted synergistically through improvement in many risk factors associated with cardiovascular disease.
Scott K, Powers   +3 more
openaire   +2 more sources

Cardioprotective MicroRNAs

Pediatric Cardiology, 2011
MicroRNAs (miRNAs) are involved in almost every aspect of a mammalian cell's functionality, from stem cell differentiation to aging and pathogenesis; however, their role in immediate cell signaling is less defined. This has been recently demonstrated by the rapid increase or decrease of miR-21's abundance within minutes of activation or inhibition of ...
openaire   +2 more sources

Mitochondria and cardioprotection

Heart Failure Reviews, 2007
Major factors linking mitochondrial dysfunction with myocardial injury are analyzed along with protective mechanisms elicited by endogenous processes and pharmacological treatments. In particular, a reduced rate of ATP hydrolysis and a slight increase in ROS formation appear to represent the prevailing components of self-defense mechanisms, especially ...
DI LISA, FABIO   +4 more
openaire   +5 more sources

Aging and cardioprotection

Journal of Applied Physiology, 2007
Advanced age is a strong independent predictor for death, disability, and morbidity in patients with structural heart disease. With the projected increase in the elderly population and the prevalence of age-related cardiovascular disabilities worldwide, the need to understand the biology of the aging heart, the mechanisms for age-mediated cardiac ...
Arshad, Jahangir   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy